Shiqiong Zhou

H&E to recurrence score: A step forward, but not yet a substitute for genomic testing

Shamai and colleagues developed a multimodal deep-learning model that predicts Oncotype DX recurrence scores from routine H&E slides and clinicopathological variables in hormone receptor‑positive, HER2‑negative early breast cancer. Validated across the TAILORx trial and six exter...